Melanoma Focus Virtual Regional Meeting

Friday 13th May 2022

Organised by Dr Miranda Payne

Registration for this event is now open

The Melanoma Focus virtual meeting May 2022 has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credit(s).

The Royal College of Surgeons of England has awarded up to 5.25 CPD points and the British Association of Plastic, Reconstructive and Aesthetic Surgeons has awarded up to 8.5 CME credits

2022 Registration Fees:

Member Rates

Earlybird
(ends 17/04/22)
Late
registration
ConsultantOpen Form£89£109
Other Clinician/AHPOpen Form£69£79
Nurse/medical studentOpen Form£25£35

Non-Member Rates

Earlybird
(ends 17/04/22)
Late
registration
ConsultantOpen Form£129£149
Other Clinician/AHPOpen Form£85£99
Nurse/medical studentOpen Form£45£55
IndustryOpen Form£169£169

Programme

09:00 - 09:15

Welcome/Introductions
Dr Mark Harries/Dr Miranda Payne/Susanna Daniels

09:15 - 10:00

Stage II Melanoma: Developments as a result from advances in systemic therapies

Associate Professor Alexander van Akkooi, Chair of Melanoma Surgery, Melanoma Institute of Australia

09:15 – 12:30

Pharma Exhibition Area / Posters

10:10 – 10:50

Virtual Networking:
My Melanoma: Mark Middleton

11:00 – 12:00

Pharma Sponsored Symposium: Novartis

Survivorship – A new treatment goal for advanced melanoma?

12:30 – 13:35

Session 1: Molecular surveillance of melanoma
Chair: Professor Mark Middleton – Professor of Experimental Cancer Medicine in the Department of Oncology, Consultant Medical Oncologist at the Oxford Cancer and Haematology Centre

12:30 – 12:55

Circulating tumour DNA; a new tool for the clinic
Dr Rebecca Lee, Clinical Lecturer in Medical Oncology, The University of Manchester

12:55 – 13:20

Biofluid metabolomics – the other liquid biopsy for cancer detection
Dr James Larkin, Lecturer in Biochemistry, Trinity College, Oxford

13:20 – 13:35

Q&A

13:35 – 14:35

Session 2: Living beyond a stage 4 diagnosis
Chair: Lesley Howells, Maggies Lead Psychologist, Maggies Centre, Oxford

13:35 – 14:15

Caroline Kohl (10 mins), Paul Duhig (10 mins), Dr Shelley Petzer (10 mins)

14:15 – 14:35

Q&A

14:35 – 14:45

Comfort Break

14:45 – 16:30

Session 3: Practice changes in oncology

Chair: Dr Ben Fairfax, Wellcome Intermediate Clinical Fellow and Honorary Consultant Medical Oncologist

14:45 – 15:10

Using Artificial Intelligence approaches to address an unmet need for melanoma
Dr Rubeta Matin, Consultant Dermatologist and Honorary Senior Clinical Lecturer, Oxford University Hospitals NHS Foundation Trust

15:10 – 15:35

Findings from the first UK Census of Skin Cancer Specialist Nurses
Dr Pippa Corrie, Consultant Medical Oncologist, Deeya Kotecha & Jashmitha Rammanohar, Final year medical students Addenbrooke’s Hospital, Cambridge

15:35 – 16:15

Melanoma immunotherapy: response and toxicity
Professor Genevieve Boland – Section Head, Melanoma/Sarcoma Surgery, Surgical Director, Termeer Center for Targeted Therapies, Director, Surgical Oncology, Research Laboratories, Massachusetts General Hospital, Associate Professor of Surgery, Harvard Medical School

16:15 – 16:30

Q&A

16:30 – 17:25

Session 4: MDT – Management of progression on adjuvant treatment (case-based discussions)
Chair: Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre
Panel:
Mr Oliver Cassell, Consultant Plastic Surgeon, Oxford University Hospitals
Professor John Wagstaff, Professor of Medical Oncology, Swansea
Dr Steve Watkins, Consultant Oncologist, Birmingham University Hospitals
Professor Genevieve Boland, Section Head, Melanoma/Sarcoma Surgery, Surgical Director, Termeer Center for Targeted Therapies, Director, Surgical Oncology, Research Laboratories, Massachusetts General Hospital, Associate Professor of Surgery, Harvard Medical School

17:25 – 17:30

Concluding Remarks and Close
Dr Mark Harries, Chairman Melanoma Focus, Dr Miranda Payne, Organiser